Entia Biosciences Inc - ERGO - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: May 12, 2013
Entia Biosciences Inc - SIC # 8731
|Ticker||Exchange||SIC #||Website||Latest Ticker|
|ERGO||Over the counter||8731||http://www.entiabio.com||0.50 0.00|
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Entia Biosciences Inc
Entia hires director of marketing for medical foods and consumer products - May 15th, 2013 12:08 pm
ENTIA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report - May 10th, 2013 6:10 am
ENTIA BIOSCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financ - May 2nd, 2013 9:08 pm
ENTIA BIOSCIENCES, INC. Financials - Apr 5th, 2013 11:04 am
Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel - Apr 2nd, 2013 10:10 am
View All Current Headlines >>